MORTALITY AND MORBIDITY IN TREATED HYPERTENSIVE TYPE-2 DIABETIC-PATIENTS WITH MICROPROTEINURIA OR MACROPROTEINURIA

被引：19

作者：

SAWICKI, PT ^{[1
]}

MUHLHAUSER, I ^{[1
]}

DIDJURGEIT, U ^{[1
]}

REIMANN, M ^{[1
]}

BENDER, R ^{[1
]}

BERGER, M ^{[1
]}

机构：

[1] UNIV DUSSELDORF,COLLABORATING CTR DIABET,WHO,MED DEPT METAB DIS & NUTR,DUSSELDORF,GERMANY

来源：

DIABETIC MEDICINE | 1995年 / 12卷 / 10期

关键词：

DIABETES MELLITUS; PROTEINURIA; HYPERTENSION; MORTALITY; MORBIDITY;

D O I：

10.1111/j.1464-5491.1995.tb00392.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In order to describe the natural history of high risk diabetic patients treated for hypertension we have followed a sequential sample of 100 hypertensive Type 2 diabetic patients with elevated urinary protein excretion (greater than or equal to 60 mg 24 h(-1)) for a period of 1-7 years. Antihypertensive treatment was instituted in all patients and, in addition, the patients were offered the possibility of participation in an intensified antihypertensive therapy programme. After a mean follow-up of 4 years overall mortality was 13 %. Nineteen percent of all patients experienced a cardiovascular event and 7% a cerebrovascular event. In conclusion, in this study the overall mortality was lower that previously reported in proteinuric Type 2 diabetic patients. Antihypertensive treatment may account for this outcome.

引用

页码：893 / 898

页数：6

共 24 条

[11]

Mathiesen ER, Borch-Johnsen K., Jensen DV, Deckert T., Improved survival in patients with diabetic nephropathy, Diabetologia, 32, pp. 884-886, (1989)

[12]

Parving HH, Hommel E., Prognosis in diabetic nephropathy, British Medical Journal, 299, pp. 230-233, (1989)

[13]

New trials in older hypertensives, Lancet, 338, pp. 1299-1300, (1991)

[14]

Medical Research Council trial of treatment of hypertension in older adults: principal results, Br Med J, 304, pp. 405-412, (1992)

[15]

Muhlhauser I., Sawicki PT, Didjurgeit U., Jorgens V., Berger M., Uncontrolled hypertension in Type 1 diabetes: Assessment of patients' desires about treatment and improvement of blood pressure control by a structured treatment and teaching programme, Diabetic Medicine, 5, pp. 693-698, (1988)

[16]

Sawicki PT, Didjurgeit U., Muhlhauser I., Heinemann L., Berger M., Near‐normotension and near‐normoglycaemia in blind Type 1 diabetic patients with overt diabetic nephropathy, J Diab Compl, 4, pp. 179-183, (1990)

[17]

Sawicki PT, Muhlhauser I., Didjurgeit U., Reimann M., Jorgens V., Berger M., Strukturoptimierung der antihypertensiven Therapie. Langzeitergebnisse einer prospektiven Studie in Arztpraxen, Deutsches Ärzteblatt, 90, pp. 1736-1741, (1993)

[18]

Diabetes mellitus, (1985)

[19]

Sawicki PT, Heinemann L., Berger M., Comparison of methods for determination of microalbuminuria in diabetic patients, Diabetic Med, 6, pp. 412-415, (1989)

[20]

Cox DR, Regression models and life tables (with discussion), J R Statist Soc B, 34, pp. 187-220, (1972)

← 1 2 3 →